These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10617794)
1. Conformation-dependent antibody response to Pseudomonas aeruginosa outer membrane proteins induced by immunization in humans. Lee N; Ahn B; Jung SB; Kim YG; Kim H; Park WJ FEMS Immunol Med Microbiol; 2000 Jan; 27(1):79-85. PubMed ID: 10617794 [TBL] [Abstract][Full Text] [Related]
2. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy. Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346 [TBL] [Abstract][Full Text] [Related]
3. Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis. Rosenqvist E; Musacchio A; Aase A; Høiby EA; Namork E; Kolberg J; Wedege E; Delvig A; Dalseg R; Michaelsen TE; Tommassen J Infect Immun; 1999 Mar; 67(3):1267-76. PubMed ID: 10024570 [TBL] [Abstract][Full Text] [Related]
4. Role of IgG subclass response to outer-membrane proteins in inhibiting adhesion of Pseudomonas aeruginosa to epithelial cells. Morrin M; Reen DJ J Med Microbiol; 1993 Dec; 39(6):467-72. PubMed ID: 8246267 [TBL] [Abstract][Full Text] [Related]
5. Determination of IgG subclass antibodies to Pseudomonas aeruginosa outer membrane proteins in cystic fibrosis lung infection using immunoblotting and enzyme-linked immunosorbent assay. Pressler T; Kronborg G; Shand GH; Mansa B; Høiby N Med Microbiol Immunol; 1992; 181(6):339-49. PubMed ID: 1287420 [TBL] [Abstract][Full Text] [Related]
6. Antibody response against Pseudomonas aeruginosa membrane proteins in experimentally infected sheep. Chin JC; Dai Y; Watts JE Vet Microbiol; 1995 Jan; 43(1):21-32. PubMed ID: 7716881 [TBL] [Abstract][Full Text] [Related]
7. Human immune response to a Pseudomonas aeruginosa outer membrane protein vaccine. Jang IJ; Kim IS; Park WJ; Yoo KS; Yim DS; Kim HK; Shin SG; Chang WH; Lee NG; Jung SB; Ahn DH; Cho YJ; Ahn BY; Lee Y; Kim YG; Nam SW; Kim HS Vaccine; 1999 Jan; 17(2):158-68. PubMed ID: 9987150 [TBL] [Abstract][Full Text] [Related]
8. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection. Zaidi TS; Priebe GP; Pier GB Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743 [TBL] [Abstract][Full Text] [Related]
9. Antibody response to outer-membrane antigens of Pseudomonas aeruginosa in human burn wound infection. Ward KH; Anwar H; Brown RW; Wale J; Gowar J J Med Microbiol; 1988 Nov; 27(3):179-90. PubMed ID: 3143013 [TBL] [Abstract][Full Text] [Related]
10. Enterobacterial 38-kDa outer membrane protein is an age-dependent molecular marker of innate immunity and immunoglobulin deficiency as results from its reactivity with IgG and IgA antibody. Witkowska D; Masłowska E; Staniszewska M; Szostko B; Jankowski A; Gamian A FEMS Immunol Med Microbiol; 2006 Nov; 48(2):205-14. PubMed ID: 17064276 [TBL] [Abstract][Full Text] [Related]
11. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia. Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against human muscle enolase recognize a 45-kDa bacterial cell wall outer membrane enolase-like protein. Witkowska D; Pietkiewicz J; Szostko B; Danielewicz R; Masłowski L; Gamian A FEMS Immunol Med Microbiol; 2005 Jul; 45(1):53-62. PubMed ID: 15985223 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody to an aminoglycoside-resistance factor from Pseudomonas aeruginosa. Norris SA; Sciortino CV J Infect Dis; 1988 Dec; 158(6):1324-8. PubMed ID: 3143766 [TBL] [Abstract][Full Text] [Related]
14. Comparison of two immunization schedules for a Pseudomonas aeruginosa outer membrane proteins vaccine in burn patients. Kim DK; Kim JJ; Kim JH; Woo YM; Kim S; Yoon DW; Choi CS; Kim I; Park WJ; Lee N; Jung SB; Ahn BY; Nam SW; Yoon SM; Choi WJ Vaccine; 2000 Dec; 19(9-10):1274-83. PubMed ID: 11137267 [TBL] [Abstract][Full Text] [Related]
15. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Theilacker C; Coleman FT; Mueschenborn S; Llosa N; Grout M; Pier GB Infect Immun; 2003 Jul; 71(7):3875-84. PubMed ID: 12819072 [TBL] [Abstract][Full Text] [Related]
16. Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies. Rosenqvist E; Høiby EA; Bjune G; Bryn K; Closs O; Feiring B; Klem A; Nøkleby H; Frølm LO NIPH Ann; 1991 Dec; 14(2):169-79; discussion 180-1. PubMed ID: 1687481 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection. von Specht BU; Strigl G; Ehret W; Brendel W Infection; 1987; 15(5):408-12. PubMed ID: 3121520 [TBL] [Abstract][Full Text] [Related]